Athenex, Inc. (ATNX): Price and Financial Metrics

Athenex, Inc. (ATNX): $0.20

0.06 (-23.39%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

ATNX Price/Volume Stats

Current price $0.20 52-week high $23.80
Prev. close $0.27 52-week low $0.20
Day low $0.20 Volume 1,880,200
Day high $0.26 Avg. volume 194,316
50-day MA $1.15 Dividend yield N/A
200-day MA $4.04 Market Cap 1.76M

ATNX Stock Price Chart Interactive Chart >


Athenex, Inc. (ATNX) Company Bio


Athenex Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. The company was founded in 2003 and is based in Buffalo, New York.


ATNX Latest News Stream


Event/Time News Detail
Loading, please wait...

ATNX Latest Social Stream


Loading social stream, please wait...

View Full ATNX Social Stream

Latest ATNX News From Around the Web

Below are the latest news stories about ATHENEX INC that investors may wish to consider to help them evaluate ATNX as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

We're starting off the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on Monday morning!

William White on InvestorPlace | May 15, 2023

SOFI Stock Sinks 10% on Analyst Downgrade

SoFi Technologies (SOFI) stock is on the move Monday after the finance company's stock was hit with a downgrade Wedbush.

William White on InvestorPlace | May 15, 2023

Why Is Athenex (ATNX) Stock Down 54% Today?

Athenex (ATNX) stock is falling on Monday after the company announced an agreement with lenders to pursue an expedited sales process.

William White on InvestorPlace | May 15, 2023

Why Is Greenbrook TMS (GBNH) Stock Down 9% Today?

Greenbrook TMS (GBNH) stock is on the move Monday as the therapy center prepares to release its latest earnings report later today.

William White on InvestorPlace | May 15, 2023

Athenex Voluntarily Filed For Chapter 11 Proceedings, Shares Plunge

On Sunday, Athenex Inc (NASDAQ: ATNX) and certain of its subsidiaries voluntarily filed for Chapter 11 proceedings. Athenex agreed with its lenders to move forward with an expedited sale process of its assets, the company said in a statement. The company has listed estimated assets and liabilities of around $100 million-$500 million, Reuters reported citing a filing with the U.S. Bankruptcy Court for the Southern District of Texas. The company said the assets would be sold across its primary bus

Yahoo | May 15, 2023

Read More 'ATNX' Stories Here

ATNX Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -99.79%
5-year -99.93%
YTD N/A
2023 0.00%
2022 -89.15%
2021 -87.70%
2020 -27.57%
2019 20.33%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!